scholarly journals Efficacy and Safety of Using Autologous Dendritic Cells Combined with Cytokine-Induced Killer Cells as an Adjuvant Therapy on Advanced Malignant Melanoma

2018 ◽  
Vol 04 (01) ◽  
Author(s):  
Keqian Zhang
Keyword(s):  
Dendritic Cells ◽  
Malignant Melanoma ◽  
Adjuvant Therapy ◽  
Efficacy And Safety ◽  
Killer Cells ◽  
Advanced Malignant Melanoma

Phase I/II trial of vaccine therapy with tumor-RNA transfected dendritic cells in patients with advanced malignant melanoma

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 2540-2540 ◽  
Author(s):  
S. Aamdal ◽  
J. Kyte ◽  
S. Dueland ◽  
L. Mu ◽  
H. P. Gullestad ◽  
...  
Keyword(s):  
Dendritic Cells ◽  
Malignant Melanoma ◽  
Phase I ◽  
Vaccine Therapy ◽  
Advanced Malignant Melanoma

Evaluations of Combination Chemotherapy(DAC-Tam) for Advanced Malignant Melanoma. Possible Patient Groups which may Show a Good Response Rate.

2001 ◽  
Vol 63 (5) ◽  
pp. 561-568
Author(s):  
Hideki KAMIYA ◽  
Hiroyuki KANOH ◽  
Naoki ICHIHASHI ◽  
Yoshiro ICHIKI ◽  
Hajime TAKAGI ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Combination Chemotherapy ◽  
Response Rate ◽  
Good Response Rate ◽  
Advanced Malignant Melanoma ◽  
Patient Groups

scholarly journals Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma

2009 ◽  
Vol 15 (6) ◽  
pp. 2166-2173 ◽  
Author(s):  
Theo Nicholaou ◽  
Lisa M. Ebert ◽  
Ian D. Davis ◽  
Grant A. McArthur ◽  
Heather Jackson ◽  
...  
Keyword(s):  
T Cell ◽  
Malignant Melanoma ◽  
Regulatory T Cell ◽  
T Cell Responses ◽  
Cell Responses ◽  
Advanced Malignant Melanoma
Sign in / Sign up

Export Citation Format

Share Document